April 6 (Reuters) - Cynata Therapeutics Ltd (CYP) :
- RECEIVED FIRM COMMITMENTS FOR A A$5.0 MILLION PLACEMENT AT AN OFFER PRICE OF A$0.215 PER SHARE
- PROCEEDS TO FUND CO'S CLINICAL PROGRAM INCLUDING PROPOSED PHASE 2 CLINICAL TRIAL IN ACUTE GRAFT-VERSUS-HOST DISEASE
- WILL OFFER ELIGIBLE SHAREHOLDERS OPPORTUNITY TO PARTICIPATE IN SHARE PURCHASE PLAN WHICH WILL BE CAPPED AT A$2.0M
News: CYP Cynata Therapeutics Receives Firm Commitments For A$5.0 Million Placement
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.3¢ |
Change
-0.003(1.28%) |
Mkt cap ! $45.70M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 19.3¢ | $1.078K | 5.569K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 11.40am 16/09/2025 (20 minute delay) ? |
| CYP (ASX) Chart |